Heart and brain interconnection - Clinical implications of changes in brain function during heart failure

Circulation Journal

Volumn 79, Issue 5, 2015, Pages 942-947

  Kim, Min Seok ^a   Kim, Jae Joong ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Brain; Cerebral metabolism; Cerebrovascular circulation; Cognitive function; Heart failure

Indexed keywords

4 AMINOBUTYRIC ACID; ANGIOTENSIN II; BRAIN NATRIURETIC PEPTIDE; CHOLINE; CREATINE; GLUTAMIC ACID; INOSITOL; N ACETYLASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE;

ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN METABOLISM; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; CONGESTIVE CARDIOMYOPATHY; ECHOGRAPHY; GRAY MATTER; HEART FAILURE; HEART FUNCTION; HEART TRANSPLANTATION; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MENTAL PERFORMANCE; META ANALYSIS (TOPIC); NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SCINTIANGIOGRAPHY; WHITE MATTER; ADRENERGIC SYSTEM; BLOOD FLOW VELOCITY; BRAIN; BRAIN CIRCULATION; HEART; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

BLOOD FLOW VELOCITY; BRAIN; CEREBROVASCULAR CIRCULATION; HEART; HEART FAILURE; HUMANS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84928473275     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0360     Document Type: Article

References (74)

1. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341: 577-585.
2. Bouma GJ, Muizelaar JP. Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulation. J Neurosurg 1990; 73: 368-374.
3. Lee CW, Lee JH, Kim JJ, Park SW, Hong MK, Kim ST, et al. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy. J Am Coll Cardiol 1999; 33: 1196-1202.
4. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: A systematic review of the literature. Eur J Heart Fail 2007; 9: 440-449.
5. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: The altered inhibitory mechanisms. Acta Physiol Scand 2003; 177: 17-26.
6. Poulain DA, Wakerley JB. Electrophysiology of hypothalamic magnocellular neurones secreting oxytocin and vasopressin. Neuroscience 1982; 7: 773-808.
7. Swanson LW, Sawchenko PE. Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983; 6: 269-324.
8. Badoer E. Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 2001; 28: 95-99.
9. Badoer E. Role of the hypothalamic PVN in the regulation of renal sympathetic nerve activity and blood flow during hyperthermia and in heart failure. Am J Physiol Renal Physiol 2010; 298: F839-F846.
10. Zhang K, Li YF, Patel KP. Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1006-R1015.
11. Zhang K, Patel KP. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: Role of GABA. Am J Physiol 1998; 275: R728-R734.
12. Miyawaki T, Minson J, Arnolda L, Chalmers J, Llewellyn-Smith I, Pilowsky P. Role of excitatory amino acid receptors in cardiorespiratory coupling in ventrolateral medulla. Am J Physiol 1996; 271: R1221-R1230.
13. Felder RB, Francis J, Zhang ZH, Wei SG, Weiss RM, Johnson AK. Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol 2003; 284: R259-R276.
14. Oldfield BJ, Davern PJ, Giles ME, Allen AM, Badoer E, McKinley MJ. Efferent neural projections of angiotensin receptor (AT1) expressing neurones in the hypothalamic paraventricular nucleus of the rat. J Neuroendocrinol 2001; 13: 139-146.
15. Ferguson AV, Washburn DL. Angiotensin II: A peptidergic neurotransmitter in central autonomic pathways. Prog Neurobiol 1998; 54: 169-192.
16. Skinner JE. Neurocardiology shows that the central, not peripheral, action of propranolol reduces mortality following acute coronary artery occlusion in the conscious pig. Integr Physiol Behav Sci 1991; 26: 85-97.
17. Li YF, Cornish KG, Patel KP. Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circ Res 2003; 93: 990-997.
18. Costanzo MR, Augustine S, Bourge R, Bristow M, O’Connell JB, Driscoll D, et al. Selection and treatment of candidates for heart transplantation: A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995; 92: 3593-3612.
19. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb- People KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050-1053.
20. Wanless RB, Anand IS, Gurden J, Harris P, Poole-Wilson PA. Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: Effects of isosorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther 1987; 243: 1101-1106.
21. Gruhn N, Larsen FS, Boesgaard S, Knudsen GM, Mortensen SA, Thomsen G, et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001; 32: 2530-2533.
22. Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, Kim YH, et al. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2006; 97: 1365-1369.
23. Lee KJ, Yoo SJ, Holtby H, Grant B, Mroczek D, Wong D, et al. Acute effects of the ACE inhibitor enalaprilat on the pulmonary, cerebral and systemic blood flow and resistance after the bidirectional cavopulmonary connection. Heart 2011; 97: 1343-1348.
24. Zuccala G, Onder G, Marzetti E, Monaco MR, Cesari M, Cocchi A, et al; GIFA Study Group. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 2005; 26: 226-233.
25. Thorin E, Lucas M, Cernacek P, Dupuis J. Role of ET(A) receptors in the regulation of vascular reactivity in rats with congestive heart failure. Am J Physiol Heart Circ Physiol 2000; 279: H844-H851.
26. Loncar G, Bozic B, Lepic T, Dimkovic S, Prodanovic N, Radojicic Z, et al. Relationship of reduced cerebral blood flow and heart failure severity in elderly males. Aging Male 2011; 14: 59-65.
27. Ueda T, Mizushige K, Yukiiri K, Takahashi T, Kohno M. Improvement of cerebral blood flow by olprinone, a phosphodiesterase-3 inhibitor, in mild heart failure. Cerebrovasc Dis 2003; 16: 396-401.
28. Vorstrup S, Barry DI, Jarden JO, Svendsen UG, Braendstrup O, Graham DI, et al. Chronic antihypertensive treatment in the rat reverses hypertension-induced changes in cerebral blood flow autoregulation. Stroke 1984; 15: 312-318.
29. Kim MS, Kim JS, Yun SC, Lee CW, Song JK, Park SW, et al. Association of cerebral blood flow with the development of cardiac death or urgent heart transplantation in patients with systolic heart failure. Eur Heart J 2012; 33: 354-362.
30. Cicoira M, Zanolla L, Latina L, Rossi A, Golia G, Brighetti G, et al. Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with’classical’ clinical diagnosis of idiopathic dilated cardiomyopathy. Eur J Heart Fail 2001; 3: 323-330.
31. Mann-Rouillard V, Fishbein MC, Naqvi TZ, DonMichael TA, Siegel RJ. Frequency of echocardiographic improvement in left ventricular cavity size and contractility in idiopathic-dilated cardiomyopathy. Am J Cardiol 1999; 83: 131-133.
32. Kim MS, Kim JS, Kim YR, Han SB, Kim DH, Song JM, et al. Cerebral blood flow as a marker for recovery of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy. J Card Fail 2012; 18: 549-555.
33. Zelis R, Sinoway LI, Musch TI, Davis D, Just H. Regional blood flow in congestive heart failure: Concept of compensatory mechanisms with short and long time constants. Am J Cardiol 1988; 62: 2E-8E.
34. Saxena PR, Schoemaker RG. Organ blood flow protection in hypertension and congestive heart failure. Am J Med 1993; 94: 4S-12S.
35. Mink JW, Blumenschine RJ, Adams DB. Ratio of central nervous system to body metabolism in vertebrates: Its constancy and functional basis. Am J Physiol 1981; 241: R203-R212.
36. Ebert D, Haller RG, Walton ME. Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J Neurosci 2003; 23: 5928-5935.
37. Marin-Valencia I, Good LB, Ma Q, Malloy CR, Pascual JM. Heptanoate as a neural fuel: Energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain. J Cereb Blood Flow Metab 2013; 33: 175-182.
38. Soengas JL, Aldegunde M. Energy metabolism of fish brain. Comp Biochem Physiol B Biochem Mol Biol 2002; 131: 271-296.
39. Lee CW, Lee JH, Lim TH, Yang HS, Hong MK, Song JK, et al. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. Circulation 2001; 103: 2784-2787.
40. Lee CW, Lee JH, Yang HS, Lim KH, Ahn JM, Hong MK, et al. Effects of heart transplantation on cerebral metabolic abnormalities in patients with congestive heart failure. J Heart Lung Transplant 2006; 25: 353-355.
41. Soher BJ, Hurd RE, Sailasuta N, Barker PB. Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 1996; 36: 335-339.
42. Clark JF, Cecil KM. Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes. Pediatr Res 2015; 77: 398-405.
43. Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia: Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991; 88: 303-309.
44. Ross B, Kreis R, Ernst T. Clinical tools for the 90s: Magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 1992; 14: 128-140.
45. Kreis R, Arcinue E, Ernst T, Shonk TK, Flores R, Ross BD. Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J Clin Invest 1996; 97: 1142-1154.
46. Borson S. Cognition, aging, and disabilities: Conceptual issues. Phys Med Rehabil Clin North Am 2010; 21: 375-382.
47. Malik AS, Giamouzis G, Georgiopoulou VV, Fike LV, Kalogeropoulos AP, Norton CR, et al. Patient perception versus medical record entry of health-related conditions among patients with heart failure. Am J Cardiol 2011; 107: 569-572.
48. Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: A review of the literature. J Cardiovasc Nurs 2003; 18: 219-242.
49. Vogels RL, Oosterman JM, van Harten B, Scheltens P, van der Flier WM, Schroeder-Tanka JM, et al. Profile of cognitive impairment in chronic heart failure. J Am Geriatr Soc 2007; 55: 1764-1770.
50. Bauer LC, Johnson JK, Pozehl BJ. Cognition in heart failure: An overview of the concepts and their measures. J Am Acad Nurse Pract 2011; 23: 577-585.
51. Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336: 251-257.
52. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: Evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997; 29: 1074-1080.
53. Kalaria VG, Passannante MR, Shah T, Modi K, Weisse AB. Effect of mitral regurgitation on left ventricular thrombus formation in dilated cardiomyopathy. Am Heart J 1998; 135: 215-220.
54. Gibbs CR, Blann AD, Watson RD, Lip GY. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: Effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 2001; 103: 1746-1751.
55. Chin BS, Blann AD, Gibbs CR, Chung NA, Conway DG, Lip GY. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Eur J Clin Invest 2003; 33: 941-948.
56. de la Torre JC. Is Alzheimer’s disease a neurodegenerative or a vascular disorder?: Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184-190.
57. Woo MA, Macey PM, Fonarow GC, Hamilton MA, Harper RM. Regional brain gray matter loss in heart failure. J Appl Physiol 2003; 95: 677-684.
58. Alves TC, Busatto GF. Regional cerebral blood flow reductions, heart failure and Alzheimer’s disease. Neurol Res 2006; 28: 579-587.
59. Alves TC, Rays J, Fraguas R Jr, Wajngarten M, Meneghetti JC, Prando S, et al. Localized cerebral blood flow reductions in patients with heart failure: A study using 99 mTc-HMPAO SPECT. J Neuroimaging 2005; 15: 150-156.
60. Busatto GF, Garrido GE, Almeida OP, Castro CC, Camargo CH, Cid CG, et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease. Neurobiol Aging 2003; 24: 221-231.
61. Zimpfer D, Wieselthaler G, Czerny M, Fakin R, Haider D, Zrunek P, et al. Neurocognitive function in patients with ventricular assist devices: A comparison of pulsatile and continuous blood flow devices. ASAIO J 2006; 52: 24-27.
62. Staniforth AD, Kinnear WJ, Cowley AJ. Cognitive impairment in heart failure with Cheyne-Stokes respiration. Heart 2001; 85: 18-22.
63. Alosco ML, Spitznagel MB, Sweet LH, Josephson R, Hughes J, Gunstad J. Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure. Pacing Clin Electrophysiol 2015; 38: 178-186.
64. Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R. Left ventricular dysfunction: A clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 1997; 63: 509-512.
65. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 1999; 54: M357-M364.
66. Berry C, McMurray J. A review of quality-of-life evaluations in patients with congestive heart failure. Pharmacoeconomics 1999; 16: 247-271.
67. Rengo F, Acanfora D, Trojano L, Scognamiglio P, Ciaburri F, Ceriello A, et al. Congestive heart failure and cognitive impairment in the elderly. Arch Gerontol Geriatr 1995; 20: 63-68.
68. Rogers AE, Addington-Hall JM, Abery AJ, McCoy AS, Bulpitt C, Coats AJ, et al. Knowledge and communication difficulties for patients with chronic heart failure: Qualitative study. BMJ 2000; 321: 605-607.
69. Dodson JA, Chaudhry SI. Geriatric conditions in heart failure. Curr Cardiovasc Risk Rep 2012; 6: 404-410.
70. Persad CC, Jones JL, Ashton-Miller JA, Alexander NB, Giordani B. Executive function and gait in older adults with cognitive impairment. J Gerontol A Biol Sci Med Sci 2008; 63: 1350-1355.
71. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: A population- based cohort study. Arch Intern Med 2006; 166: 1003-1008.
72. Croft JB, Giles WH, Pollard RA, Keenan NL, Casper ML, Anda RF. Heart failure survival among older adults in the United States: A poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med 1999; 159: 505-510.
73. Dodson JA, Truong TT, Towle VR, Kerins G, Chaudhry SI. Cognitive impairment in older adults with heart failure: Prevalence, documentation, and impact on outcomes. Am J Med 2013; 126: 120-126.
74. Huijts M, van Oostenbrugge RJ, Duits A, Burkard T, Muzzarelli S, Maeder MT, et al. Cognitive impairment in heart failure: Results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial. Eur J Heart Fail 2013; 15: 699-707.